Guido A. Schoenenberger, M.D.
Biography & Research Background
Guido A. Schoenenberger was a biochemist at the University of Basel, Switzerland (Research Division, Department of Surgery). Working alongside Marcel Monnier, he was responsible for the biochemical isolation, characterization, and synthesis of DSIP — determining the nonapeptide's amino acid sequence (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu). He proposed the 'programming' hypothesis, suggesting DSIP acts as a modulator of neurotransmitters rather than a direct transmitter. Key publications include 'Characterization, properties and multivariate functions of Delta-Sleep-Inducing Peptide' (1984). Guido Schoenenberger is referenced as the co-discoverer and synthesizer of DSIP. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Guido A. Schoenenberger, M.D. is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Guido A. Schoenenberger, M.D. is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.